Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Moulder

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Cancer Communications|May 1, 1991
Prediction of tumor radiosensitivity by hexafluoromisonidazole retention monitored by [1H]/[19F] magnetic resonance spectroscopyS J Li, G Y Jin, J E Moulder
International Journal of Radiation Oncology, Biology, Physics|September 1, 1993
Treatment of radiation nephropathy with ACE inhibitorsJ E Moulder, B L Fish, E P Cohen
The British Journal of Cancer. Supplement|June 1, 1978
Effect of combined metronidazole and DMSO on tumour control and skin tolerance in the ratJ E Moulder, P S Lo, J J Fischer
Radiation Research|December 1, 1992
Treatment of radiation nephropathy with captoprilE P Cohen, B L Fish, J E Moulder
Investigative Ophthalmology & Visual Science|April 1, 1986
The immune system in experimental Pseudomonas keratitis. Model and early effectsS S Twining, K M Lohr, J E Moulder
Radiation Research|November 7, 1998
Brief pharmacological intervention in experimental radiation nephropathyJ E Moulder, B L Fish, E P Cohen
Current Pharmaceutical Design|May 18, 2007
Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonistsJ E Moulder, B L Fish, E P Cohen
Current Pharmaceutical Design|February 7, 2003
ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathyJ E Moulder, B L Fish, E P Cohen
Lancet (London, England)|October 12, 2001
Radiation nephropathy caused by yttrium 90E P Cohen, J E Moulder, M E Robbins
Cancer Treatment Reports|May 1, 1978
Effect of actinomycin D and neoarsphenamine on tumor control and skin tolerance in the ratJ E Moulder, P S Lo, J J Fischer
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Cancer Communications|May 1, 1991
Prediction of tumor radiosensitivity by hexafluoromisonidazole retention monitored by [1H]/[19F] magnetic resonance spectroscopyS J Li, G Y Jin, J E Moulder
International Journal of Radiation Oncology, Biology, Physics|September 1, 1993
Treatment of radiation nephropathy with ACE inhibitorsJ E Moulder, B L Fish, E P Cohen
The British Journal of Cancer. Supplement|June 1, 1978
Effect of combined metronidazole and DMSO on tumour control and skin tolerance in the ratJ E Moulder, P S Lo, J J Fischer
Radiation Research|December 1, 1992
Treatment of radiation nephropathy with captoprilE P Cohen, B L Fish, J E Moulder
Investigative Ophthalmology & Visual Science|April 1, 1986
The immune system in experimental Pseudomonas keratitis. Model and early effectsS S Twining, K M Lohr, J E Moulder
Radiation Research|November 7, 1998
Brief pharmacological intervention in experimental radiation nephropathyJ E Moulder, B L Fish, E P Cohen
Current Pharmaceutical Design|May 18, 2007
Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonistsJ E Moulder, B L Fish, E P Cohen
Current Pharmaceutical Design|February 7, 2003
ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathyJ E Moulder, B L Fish, E P Cohen
Lancet (London, England)|October 12, 2001
Radiation nephropathy caused by yttrium 90E P Cohen, J E Moulder, M E Robbins
Cancer Treatment Reports|May 1, 1978
Effect of actinomycin D and neoarsphenamine on tumor control and skin tolerance in the ratJ E Moulder, P S Lo, J J Fischer
Pageof 11